Skip to content
Back to Investors
Archangels

Archangels

Venture Capital

World-leading business angel syndicate investing in early-stage Scottish life sciences and technology companies.

Portfolio

16

companies

Investment by month

By category

  • BioTech£14.3M
  • IndustrialTech£11.1M
  • MedTech£10.2M
  • CleanTech£7.5M
  • AI/ML£6.1M
  • Other£13.8M

By location

  • Edinburgh£35.8M
  • Stirling£11.1M
  • Glasgow£10.1M
  • Bathgate£6.0M

Portfolio companies

1nhaler

1nhaler

Developer of a novel paper-based dry powder inhaler platform.

A

Administrate

Administrate builds software to automate and manage training and learning delivery.

B

BDD

BDD develops drug formulation technology and provides specialist clinical trial services for the pharmaceutical sector.

BD

Bio-Images Drug Delivery

Bio-Images Drug Delivery develops precision timed drug release technology for pharmaceutical treatments.

B

Biocaptiva

Biocaptiva develops technology designed to improve liquid biopsy testing for cancer management.

Bioliberty

Bioliberty

Bioliberty builds soft robotic gloves and digital therapy platforms for stroke rehabilitation.

View all 16 companies

Team

Sarah Hardy

Sarah Hardy

Head of New Investments and Director

Sarah brings investment and board experience in Scottish healthcare and deep tech companies, following roles with Archangels and the Roslin Foundation.

LinkedIn
Niki McKenzie

Niki McKenzie

Joint Managing Director

Niki is joint managing director at Archangel Investors Limited, having previously served as investment director at the same firm. She also holds non-executive board and chair roles across Scottish investment and public bodies.

LinkedIn
IM

Ian MacLeod

Chairman of the Board

Eric Young

Eric Young

Former Chairman

Eric brings extensive directorship experience, having previously chaired Archangels and held board roles across property, energy, and investment firms. He currently serves as a director at Our Net Energy, Airds Capital, and Miller Developments, alongside trustee and governance positions.

LinkedIn
TA

Tim Allan

Founder and Director of Motor Fuel Group

Tim serves as president of the Scottish Chambers of Commerce and holds non-executive roles with Archangel Investors and the University of St Andrews. He also brings board experience from Motor Fuel Group.

LinkedIn
MK

Maureen Kinsler

Partner

Maureen brings intellectual property experience, having served as a partner at Marks & Clerk and principal at Schwegman Lundberg and Woessner, alongside her role as a board member at Archangel Investors.

LinkedIn
View all 11 team members
MM

Mike MacPhee

Retired Partner

Andrew Sealey

Andrew Sealey

CEO

Andrew brings extensive experience from his long tenure as chief executive officer of Campbell Lutyens, where he now serves as chairman. He also contributes as a non-executive director at Archangel Investors Limited.

LinkedIn
David Ovens

David Ovens

Joint MD

David serves as joint managing director at Archangel Investors and chairs Scottish Athletics. He also holds non-executive directorships at Northern 3 Vct and UK Athletics.

LinkedIn
PB

Paddy Baxter

Dan McKiddie

Dan McKiddie

Investment Manager

Dan brings investment management and transaction services experience from roles at Archangel Investors, Inverleith, and PwC.

LinkedIn

Recent investments

£6.0M

The funding was led by PXN Ventures with participation from Scottish Enterprise, Archangels and the European Space Agency.

"Businesses are increasingly aware that nature loss and climate risks have direct implications for financial performance, supply chains and long-term resilience. The challenge is turning complex environmental data into information that can support real business decisions. Earth Blox was built to bridge that gap, helping organisations see clearly where environmental change affects value and where investment today can strengthen future performance."
— Genevieve Patenaude, CEO and founder
£1.6M

The funding round was led by Archangels to support product development and market entry.

"Oncology is an exciting and vibrant sector. The scientists and technologists have been doing incredible things based upon the samples that they’re given, but there hasn’t been any particular movement in how the samples are prepared for years. Our msX platform has the potential to revolutionise how samples are collected, allowing for larger samples, faster extraction, simpler processing, and fully automatable capabilities."
— Jeremy Wheeler
Seed
£1.5M

The financing will support clinical material manufacture and preparation for regulatory studies ahead of a target marketing authorisation application.

"This additional funding represents strong continued confidence in our technology platform and our progress towards commercialisation. The support from Archangels, Scottish Enterprise and BBB Investments is enabling us to advance our clinical and manufacturing capabilities as we work towards regulatory approval."
— Lisa McMyn, Chief Executive Officer
Series A
£6.0M

The round was led by Archangels, Par Equity, and Scottish Enterprise to accelerate product development and international growth.

"This investment reflects the growing recognition of the critical need for innovative communication solutions in the underwater IoT sector. The support from our investors will allow us to scale our operations, enhance our product offerings and help industries worldwide manage their resources more effectively. We are grateful for their trust and excited to shape the future of underwater communication."
— Jonathan Reeves, CEO
Seed
£6.1M

The seed round was led by Blackfinch Ventures to support global growth and commercial adoption.

"This investment marks a significant step forward as we continue pioneering new applications for magnetic sensing. With the support of our investors, we are expanding our team, advancing our technology, and bringing our solutions closer to widespread adoption."
— Noel McKenna, CEO